Most Innovative Magnetic Injection Delivery System 2020
Otomagnetics, a University of Maryland College Park spin-out, is developing a non-invasive method to deliver drugs and other therapeutic payloads to inner and middle ear compartments, to the eye, and into the skin. The inner ear is behind the blood-labyrinth barrier – vessels that supply blood to the inner ear have walls that are impermeable to most drug molecules, and thus it is a challenge to deliver therapy to treat inner ear diseases.
The product combines our proprietary device (a magnetic injector) with bio-degradable magnetic particles (composed solely out of materials approved by the FDA for injection into the body). These particles may be able to carry essentially any therapy (drugs, proteins, or genes).